Citadel Advisors’s Monarch Blue Chips Elite Index ETF MBCE Stock Holding History

Citadel Advisors’s Portfolio MBCE Stock Details MBCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,722	Closed	-$471K	–	14872
2023 Q1	$471K	Buy	18,722 +8,607	+85%	+$211K	﹤0.01%	8442
2022 Q4	$240K	Sell	10,115 -10,558	-51%	-$244K	﹤0.01%	9780
2022 Q3	$440K	Buy	+20,673	New	+$490K	﹤0.01%	8742
2021 Q4	–	Sell	-10,903	Closed	-$310K	–	14364
2021 Q3	$310K	Buy	+10,903	New	+$315K	﹤0.01%	11009

Other funds holding MBCE

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's MBCE Position: Q2 2023 in Review

Citadel Advisors sold out of Monarch Blue Chips Elite Index ETF (MBCE) in Q2 2023, closing a stake of 18,722 shares — an estimated $471K sold.

Citadel Advisors first reported a position in MBCE in Q3 2021 and held it in 4 quarters. The position peaked at $471K in Q1 2023. 4 funds tracked by Wall St. Rank hold MBCE as of Q2 2023.

Citadel Advisors reported no remaining Monarch Blue Chips Elite Index ETF position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 18,722 Monarch Blue Chips Elite Index ETF shares in Q2 2023, an estimated $471K.
Citadel Advisors first reported a position in Monarch Blue Chips Elite Index ETF in Q3 2021 and held it in 4 quarters.
Citadel Advisors's Monarch Blue Chips Elite Index ETF position peaked at $471K in Q1 2023.
4 funds tracked by Wall St. Rank held Monarch Blue Chips Elite Index ETF as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.